Scanship Holding ASA : Notice of Extraordinary General Meeting
Please find attached notice of the Extraordinary General Meeting to be held on Wednesday 2 October 2019 at hrs. 10.00.
The notice is also being sent to the company's shareholders.
For further queries, please contact:
Henrik Badin - CEO
Scanship Holding ASA
Tel: +47 90 78 98 25
ABOUT SCANSHIP HOLDING ASA
Scanship delivers world leading solutions for cleaner oceans in the Cruise and Aquaculture industries. Scanship provides advanced technologies for processing waste and purifying wastewater. Owners operating Scanship systems have the solution to convert all waste and wastewater into clean energy and purified water which meets the highest international discharge standards. Any residuals from the Scanship processes can be recovered for reuse.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Mandalay Resources Provides Target Release Date for Second Quarter 2020 Financial Results and Conference Call6.8.2020 23:44:00 CEST | Press release
TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (“Mandalay” or “the Company”) (TSX: MND, OTCQB: MNDJF) today announced that its second quarter 2020 financial results will be released after market close on August 12, 2020, followed by a conference call with Dominic Duffy, President and Chief Executive Officer of Mandalay, for investors and analysts on August 13, 2020, at 8:00 AM (Toronto time). Analysts and interested investors are invited to participate using the following dial-in numbers: Participant Number: (201) 689-8341Participant Number (Toll free): (877) 407-8289Conference ID:13708185 A replay of the conference call will be available until 11:59 PM (Toronto time), August 27, 2020, and can be accessed using the following dial-in number: Encore Toll Free Dial-in Number: (877) 660-6853Encore ID: 13708185 For Further Information: Dominic Duffy President and Chief Executive Officer Edison Nguyen Manager, Analytics and Investor Relations Contact: (647) 260-156
CrossAmerica Partners LP Reports Second Quarter 2020 Results6.8.2020 22:15:10 CEST | Press release
Allentown, PA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Reports Second Quarter 2020 Results Reported Second Quarter 2020 Operating Income of $6.3 million and Net Income of $5.2 million compared to Operating Income of $13.9 million and Net Income of $6.4 million for the Second Quarter 2019Generated Second Quarter 2020 Adjusted EBITDA of $27.7 million and Distributable Cash Flow of $26.0 million compared to Second Quarter 2019 Adjusted EBITDA of $27.7 million and Distributable Cash Flow of $22.3 millionReported Second Quarter 2020 Gross Profit for the Wholesale Segment of $40.7 million compared to $33.4 million of Gross Profit for the Second Quarter 2019Reported Second Quarter 2020 Gross Profit for the Retail Segment of $15.9 million compared to $8.1 million of Gross Profit for the Second Quarter 2019Distributed 260.2 million wholesale fuel gallons during the Second Quarter 2020 at an average wholesale fuel margin per gallon of 10.8 centsThe Distribution Coverage Ratio
Golar LNG Partners LP: Q2 2020 results presentation6.8.2020 22:02:00 CEST | Press release
Golar LNG Partners LP 2nd Quarter 2020 results will be released before the NASDAQ opens on Thursday August 13, 2020. In connection with this a webcast presentation will be held at 4:30 P.M (London Time) on Thursday, August 13, 2020. The presentation will be available to download from the Investor Relations section at www.golarlngpartners.com Due to ongoing high levels of demand for their services, our platform providers highly recommended that participants join the conference call via the listen-only live webcast link provided. Sell-side analysts interested in raising a question during the Q&A session that will immediately follow the presentation should access the event via the conference call dial-in information below. Call handling may take longer than usual. You should therefore dial in 10-15 minutes prior to the start time. Information on how to ask questions will be given at the beginning of the Q&A session. There will be a limit of two questions per participant. a. Listen-only li
Galapagos reports solid H1 2020 progress6.8.2020 22:01:00 CEST | Press release
First half-year 2020 financial results:Group revenues and other income of €224.6 millionOperating loss of €130.8 millionNet loss of €165.6 millionCash and current financial investments on 30 June 2020 of €5.6 billion Positive CHMP opinion for filgotinib in rheumatoid arthritis (RA)Positive SELECTION Phase 3 results for filgotinib in ulcerative colitis (UC) Commercial readiness for potential European approval of filgotinib in RA in Q3On track to report topline results from three patient trials later this year Webcast presentation tomorrow, 7 August 2020, at 14.00 CET / 8 AM ET, www.glpg.com, +32 2 404 0659, code 8997710 Mechelen, Belgium; 6 August 2020, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announces its unaudited H1 results and key events, which are further detailed in its H1 2020 report available on the Galapagos website, www.glpg.com. “During the past six months, we made substantial progress despite the global pandemic. We ended the period with imp
Roche provides update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancer6.8.2020 22:00:00 CEST | Press release
Basel, 06 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMpassion131 study, evaluating Tecentriq® (atezolizumab) in combination with paclitaxel (chemotherapy), in comparison to placebo plus paclitaxel, did not meet statistical significance on its primary endpoint of progression-free survival (PFS) for the initial (first-line) treatment of people with metastatic triple-negative breast cancer (TNBC), in the PD-L1-positive population. The data for the secondary endpoint of overall survival (OS) showed a negative trend, however, the study was not powered for the secondary endpoint of OS and data were immature at time of analysis. OS follow-up is planned to continue until final analysis. Safety for the Tecentriq combination appeared to be consistent with the known safety profile of the individual medicines, and no new safety signals were identified. In the previous IMpassion130 study, Tecentriq (atezolizumab) in combination with Abraxane® (paclitaxel pr
Update: Verisk Telematics Data Integration with Honda Now Live, Providing New Opportunities for Usage-Based Insurance Innovation6.8.2020 15:26:14 CEST | Press release
The addition of Honda expands the scale of the Verisk Data Exchange™, empowering U.S. auto insurers to deliver powerful telematics-based programs to more customers Jersey City, NJ, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Verisk (Nasdaq:VRSK) announced today that for the first time, U.S. auto insurers can access driving data from consenting owners of connected Honda and Acura vehicles. The data, available exclusively through the Verisk Data Exchange™, can help insurers deliver the benefits of their usage-based insurance (UBI) programs to an expanded audience of customers. “Data from consenting Honda drivers will be available across Verisk’s portfolio of telematics products, expanding the reach of the Verisk Data Exchange and helping our insurer customers launch or scale-up their UBI programs,” said Karthik Balakrishnan, general manager of Verisk’s telematics business. “We are making more OEM data available to insurers, so they can reach more of the market and reward safe drivers.” With consum